MT-303

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMT-303
Drug Alias Nameglyceollins (MicroBiome Therapeutics)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicrobiome Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMicrobiome Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A